Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO

Isomorphic Labs is looking to develop new medicines using AI.

Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO

TL;DR

  • Isomorphic Labs, an AI drug discovery startup, raised $5 billion in a Series C funding round.
  • The company was founded by Demis Hassabis, who recently stepped down as CEO of Google DeepMind.
  • The funding will support the design and development of new medicines using AI.
  • The round was co-led by Greenoaks and Sequoia Capital, with investment from Alphabet.
  • Drug discovery startups have seen record funding in 2026, with $23.2 billion raised.
  • Isomorphic is building a proprietary AI-powered drug design engine and therapeutic pipeline.